Kimberly-Clark/$KMB
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Kimberly-Clark
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Ticker
$KMB
Sector
Primary listing
Employees
38,000
Headquarters
Website
Kimberly-Clark Metrics
BasicAdvanced
$34B
17.57
$5.91
0.31
$5.00
4.85%
Price and volume
Market cap
$34B
Beta
0.31
52-week high
$150.45
52-week low
$99.22
Average daily volume
4.9M
Dividend rate
$5.00
Financial strength
Current ratio
0.773
Quick ratio
0.366
Long term debt to equity
443.256
Total debt to equity
500.068
Dividend payout ratio (TTM)
83.80%
Interest coverage (TTM)
11.87%
Profitability
EBITDA (TTM)
3,910
Gross margin (TTM)
35.65%
Net profit margin (TTM)
9.98%
Operating margin (TTM)
15.65%
Effective tax rate (TTM)
25.02%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
11.33%
Return on equity (TTM)
136.88%
Valuation
Price to earnings (TTM)
17.573
Price to revenue (TTM)
1.748
Price to book
25.88
Price to tangible book (TTM)
-59.52
Price to free cash flow (TTM)
20.618
Free cash flow yield (TTM)
4.85%
Free cash flow per share (TTM)
5.037
Dividend yield (TTM)
4.81%
Forward dividend yield
4.85%
Growth
Revenue change (TTM)
11.62%
Earnings per share change (TTM)
-23.42%
3-year revenue growth (CAGR)
-0.75%
10-year revenue growth (CAGR)
0.44%
3-year earnings per share growth (CAGR)
3.96%
10-year earnings per share growth (CAGR)
13.87%
3-year dividend per share growth (CAGR)
2.67%
10-year dividend per share growth (CAGR)
3.69%
What the Analysts think about Kimberly-Clark
Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.
Bulls say / Bears say
Kimberly-Clark posted its strongest volume-driven organic sales growth in five years, with a 3.9% rise in Q2 2025, led by a 5% jump in volumes that lifted its outlook for full-year profits (Reuters)
The company agreed to sell a 51% stake in its international tissue business to Suzano for $3.4 billion, receiving $1.73 billion in cash, which will allow it to refocus on higher-margin personal care businesses and return capital to shareholders (Reuters)
Assets placed in the international tissue joint venture generated $500 million in EBITDA from $3.3 billion of sales in 2024, highlighting the value-creation potential of the sale (FT)
Despite beating Q3 sales estimates, gross margins contracted by 170 basis points year-over-year due to U.S. tariffs and pricing investments, underlining continued margin pressure (Reuters)
Management revised its 2025 organic sales growth target to match the broader industry average of about 2%, down from its earlier goal to outpace the market, reflecting softer demand expectations (Reuters)
Global trade policy uncertainty is forcing Kimberly-Clark to raise prices or cut earnings guidance, heightening uncertainty around consumer demand and cost recovery strategies (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2025.
Kimberly-Clark Financial Performance
Revenues and expenses
Kimberly-Clark Earnings Performance
Company profitability
Kimberly-Clark News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kimberly-Clark stock?
Kimberly-Clark (KMB) has a market cap of $34B as of November 09, 2025.
What is the P/E ratio for Kimberly-Clark stock?
The price to earnings (P/E) ratio for Kimberly-Clark (KMB) stock is 17.57 as of November 09, 2025.
Does Kimberly-Clark stock pay dividends?
Yes, the Kimberly-Clark (KMB) stock pays dividends to shareholders. As of November 09, 2025, the dividend rate is $5 and the yield is 4.85%. Kimberly-Clark has a payout ratio of 83.8% on a trailing twelve-month basis.
When is the next Kimberly-Clark dividend payment date?
The next Kimberly-Clark (KMB) dividend payment date is unconfirmed.
What is the beta indicator for Kimberly-Clark?
Kimberly-Clark (KMB) has a beta rating of 0.31. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.